Escitalopram in the treatment of major depressive disorder: A meta-analysis

By Kennedy Sidney H.   Andersen Henning F.   Thase Michael E.  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 161-175

Informa Healthcare

Access to resources Recommend Favorite

Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors

By Signorovitch James   Ramakrishnan Karthik   Ben-Hamadi Rym   Yu Andrew P.   Wu Eric Q.   Dworak Heather   Erder M. Haim  

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1089-1096

Informa Healthcare

Access to resources Recommend Favorite

Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 68, Iss. 11, 2014-11 ,pp. : 1301-1308

John Wiley & Sons Inc

Access to resources Recommend Favorite

TYPE 2 DIABETES IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A META‐ANALYSIS OF PREVALENCE ESTIMATES AND PREDICTORS

By  

DEPRESSION AND ANXIETY (ELECTRONIC), Vol. 1091-4269, Iss. 10, 2015-10 ,pp. : 763-773

John Wiley & Sons Inc

Access to resources Recommend Favorite

TYPE 2 DIABETES IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A META‐ANALYSIS OF PREVALENCE ESTIMATES AND PREDICTORS

By  

DEPRESSION AND ANXIETY (ELECTRONIC), Vol. 32, Iss. 10, 2015-10 ,pp. : 763-773

John Wiley & Sons Inc

Access to resources Recommend Favorite